Fox Chase to Participate in Virtual Philadelphia Walk to End Colon Cancer

PHILADELPHIA (August 27, 2020) - Fox Chase Cancer Center proudly supports the Philadelphia Walk to End Colon Cancer, a fundraising event organized by the Colorectal Cancer Alliance (Alliance) to raise money for colorectal cancer research, education, and awareness. In accordance with COVID-19 social distancing guidelines, the yearly walk will be held virtually on Saturday, September 12.

To register online, make a donation, or for more information, please visit https://www.foxchase.org/events/walk-end-colon-cancer.

“Although the means by which the event is being held are atypical, it still presents a great opportunity for colorectal cancer patients and their supportive communities to safely support one another and raise money for screening, support, and research,” said Fox Chase team captain Joshua E. Meyer, MD, associate professor in the Department of Radiation Oncology.

Participants will include Fox Chase faculty and staff, volunteers, survivors, friends, and family. As part of the virtual event, participants are encouraged to walk in their neighborhoods. The exact time and location of the drive-thru victory lap celebration will be announced on the Alliance website.

Philadelphia is one of 15 locations to host the Walk to End Colon Cancer.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text